Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 51, 2011, Pages 20748-20753

  Sandbulte, Matthew R ^a   Westgeest, Kim B ^b   Gao, Jin ^a   Xu, Xiyan ^c   Klimov, Alexander I ^c   Russell, Colin A ^d,e   Burke, David F ^d   Smith, Derek J ^b,d,e   Fouchier, Ron A M ^b   Eichelberger, Maryna C ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; POLYCLONAL ANTIBODY; SIALIDASE; VIRUS ANTIGEN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENIC DRIFT; ANTIGENIC MODULATION; ARTICLE; ENZYME INHIBITION; EVOLUTION; GENETIC DRIFT; HUMAN; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MOLECULAR RECOGNITION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SERUM;

MUSTELA; ORTHOMYXOVIRIDAE;

EID: 84862909175     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1113801108     Document Type: Article

References (32)

1. Webster RG, Laver WG, Air GM, Schild GC (1982) Molecular mechanisms of variation in influenza viruses. Nature 296:115-121. (Pubitemid 12160907)
2. Laver WG, Air GM, Webster RG, Markoff LJ (1982) Amino acid sequence changes in antigenic variants of type A influenza virus N2 neuraminidase. Virology 122:450-460. (Pubitemid 13234837)
3. Luther P, Bergmann KC, Oxford JS (1984) An investigation of antigenic drift of neuraminidases of influenza A (H1N1) viruses. J Hyg (Lond) 92:223-229. (Pubitemid 14028320)
4. Kilbourne ED, Johansson BE, Grajower B (1990) Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. Proc Natl Acad Sci USA 87:786-790.
5. Schulman JL, Khakpour M, Kilbourne ED (1968) Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol 2:778-786.
6. Webster RG, Reay PA, Laver WG (1988) Protection against lethal influenza with neuraminidase. Virology 164:230-237.
7. Clements ML, Betts RF, Tierney EL, Murphy BR (1986) Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wildtype virus. J Clin Microbiol 24:157-160. (Pubitemid 16090261)
8. Murphy BR, Kasel JA, Chanock RM (1972) Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med 286:1329-1332.
9. Hensley SE, et al. (2011) Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance. PLoS ONE 6:e15190.
10. Russell CA, et al. (2008) Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 26(Suppl 4):D31-D34.
11. Barr IG, et al.; Writing Committee of the World Health Organization Consultation on Northern Hemisphere Influenza Vaccine Composition for 2009-2010 (2010) Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 28: 1156-1167.
12. Smith DJ, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376. (Pubitemid 38938148)
13. Kilbourne ED, Laver WG, Schulman JL, Webster RG (1968) Antiviral activity of antiserum specific for an influenza virus neuraminidase. J Virol 2:281-288.
14. Sandbulte MR, Gao J, Straight TM, Eichelberger MC (2009) A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens. Influenza Other Respir Viruses 3:233-240.
15. Anonymous; Centers for Disease Control and Prevention (CDC) (2008) Influenza activity - United States and worldwide, 2007-08 season. MMWR Morb Mortal Wkly Rep 57:692-697.
16. de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD (2000) Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 61:94-99. (Pubitemid 30191232)
17. Bridges CB, et al. (2000) Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 284:1655-1663.
18. Xu X, Shaw M, Smith C, Cox N, Klimov A (2001) Multiple lineages co-circulation and genetic reassortment of the neuraminidase and hemagglutinin genes within influenza viruses of the same type/subtype. Int Congr Ser 1219:383-397.
19. Lentz MR, Air GM, Laver WG, Webster RG (1984) Sequence of the neuraminidase gene of influenza virus A/Tokyo/3/67 and previously uncharacterized monoclonal variants. Virology 135:257-265. (Pubitemid 14122265)
20. Gulati U, et al. (2002) Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). J Virol 76:12274-12280. (Pubitemid 35304325)
21. Air GM, Laver WG, Webster RG, Els MC, Luo M (1989) Antibody recognition of the influenza virus neuraminidase. Cold Spring Harb Symp Quant Biol 54:247-255. (Pubitemid 20177592)
22. Pushko P, et al. (2010) Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus. Vaccine 28:4771-4776.
23. Brett IC, Johansson BE (2005) Immunization against influenza A virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology 339:273-280. (Pubitemid 41169794)
24. Cate TR, et al. (2010) A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine 28:2076-2079.
25. Monto AS, Kendal AP (1973) Effect of neuraminidase antibody on Hong Kong influenza. Lancet 1:623-625.
26. Viboud C, Grais RF, Lafont BA, Miller MA, Simonsen L; Multinational Influenza Seasonal Mortality Study Group (2005) Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic. J Infect Dis 192:233-248. (Pubitemid 40993393)
27. Schulman JL, Kilbourne ED (1969) Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus. Proc Natl Acad Sci USA 63:326-333.
28. Schild GC, Newman RW (1969) Immunological relationships between the neuraminidases of human and animal influenza viruses. Bull World Health Organ 41:437-445.
29. Schulman JL (1969) The role of antineuraminidase antibody in immunity to influenza virus infection. Bull World Health Organ 41:647-650.
30. Sandbulte MR, et al. (2007) Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4:e59.
31. Palmer DF, Coleman MT, Dowdle WD, Schild GO (1975) Advanced Laboratory Techniques for Influenza Diagnosis. Immunology series no. 6 (U.S. Dept. of Health, Education, and Welfare, Washington, D.C.).
32. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779-815. (Pubitemid 24007801)